Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects.

Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1411-7. doi: 10.1158/1055-9965.EPI-07-2693.

2.
3.

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T.

Cancer Chemother Pharmacol. 2012 Jan;69(1):65-70. doi: 10.1007/s00280-011-1673-1. Epub 2011 May 21.

PMID:
21603867
4.

Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects.

Zick SM, Djuric Z, Ruffin MT, Litzinger AJ, Normolle DP, Alrawi S, Feng MR, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1930-6. doi: 10.1158/1055-9965.EPI-07-2934.

5.
6.
7.
8.
10.

Metabolism and disposition of isoflavone conjugated metabolites in humans after ingestion of kinako.

Hosoda K, Furuta T, Ishii K.

Drug Metab Dispos. 2011 Sep;39(9):1762-7. doi: 10.1124/dmd.111.038281. Epub 2011 May 26.

11.

Toxicokinetics of tetrabromobisphenol a in humans and rats after oral administration.

Schauer UM, Völkel W, Dekant W.

Toxicol Sci. 2006 May;91(1):49-58. Epub 2006 Feb 15.

PMID:
16481339
12.

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine.

Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ.

Cancer Chemother Pharmacol. 2007 Jul;60(2):171-7. Epub 2006 Oct 19.

PMID:
17051370
13.

Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers.

Juan H, Terhaag B, Cong Z, Bi-Kui Z, Rong-Hua Z, Feng W, Fen-Li S, Juan S, Jing T, Wen-Xing P.

Eur J Clin Pharmacol. 2007 Jul;63(7):663-8. Epub 2007 Apr 28.

PMID:
17468862
14.

Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.

Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC.

Int J Clin Pharmacol Ther. 2002 May;40(5):198-206.

PMID:
12051571
15.

Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats.

Suresh D, Srinivasan K.

Indian J Med Res. 2010 May;131:682-91.

PMID:
20516541
16.

Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers.

Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG.

J Agric Food Chem. 2010 Feb 24;58(4):2095-9. doi: 10.1021/jf9024807.

PMID:
20092313
17.

A liquid chromatography-tandem mass spectrometric method for quantification of curcumin-O-glucuronide and curcumin in human plasma.

Chen W, Fan-Havard P, Yee LD, Cao Y, Stoner GD, Chan KK, Liu Z.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jul 1;900:89-93. doi: 10.1016/j.jchromb.2012.05.026. Epub 2012 May 26.

18.

Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.

Garcea G, Berry DP, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):120-5.

19.

Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.

Zhongfa L, Chiu M, Wang J, Chen W, Yen W, Fan-Havard P, Yee LD, Chan KK.

Cancer Chemother Pharmacol. 2012 Mar;69(3):679-89. doi: 10.1007/s00280-011-1749-y. Epub 2011 Oct 4.

20.

Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.

Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL, Howells L, Plummer S, Jukes R, Williams M, Steward WP, Gescher A.

Cancer Res. 2001 Feb 1;61(3):1058-64.

Supplemental Content

Support Center